|
|
|
Volumn 7, Issue 11, 1997, Pages 1283-1295
|
|
Therapeutic potential of endothelin converting enzyme inhibitors
|
|
Author keywords
Endothelin; Endothelin converting enzyme; Inhibitor; Metalloprotease; Phosphoramidon
|
|
Indexed keywords
2 (4 BIPHENYLYL) 1 (1H TETRAZOL 5 YL)ETHYLAMINOMETHYLPHOSPHONIC ACID;
2 BIPHENYL 4 YL 1 (1H TETRAZOL 5 YL)ETHYLAMINOMETHYL PHOSPHONIC ACID;
5,6,8,13 TETRAHYDRO 1,6,9,14 TETRAHYDROXY 3 (2 HYDROXYPROPYL) 7 METHOXY 8,13 DIOXOBENZO[A]NAPHTHACENE 2 CARBOXYLIC ACID;
ACLARUBICIN;
ASPERGILLOMARASMINE A;
B 90063;
CGS 31447;
ENDOTHELIN 1;
ENDOTHELIN CONVERTING ENZYME;
ENDOTHELIN CONVERTING ENZYME INHIBITOR;
ENZYME INHIBITOR;
MEMBRANE METALLOENDOPEPTIDASE;
PD 089185;
PHOSPHONIC ACID DERIVATIVE;
PHOSPHORAMIDON;
S 17162;
SA 6817;
SCH 54470;
SOYASAPONIN I;
UNCLASSIFIED DRUG;
WS 75624B;
BRAIN VASOSPASM;
CONGESTIVE HEART FAILURE;
DRUG DEVELOPMENT;
DRUG SYNTHESIS;
ENZYME INHIBITION;
HEART INFARCTION;
HUMAN;
HYPERTENSION;
KIDNEY FAILURE;
PRESSOR RESPONSE;
PULMONARY HYPERTENSION;
REVIEW;
STRUCTURE ACTIVITY RELATION;
|
|
EID: 0030724152
PISSN: 13543776
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (15)
|
|
References (123)
|
